Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ALLO - Regenerative Medicines: Universal Cell Therapy Gaining Momentum

ALLO - Regenerative Medicines: Universal Cell Therapy Gaining Momentum

Allogene Therapeutics Inc.
  • Allogeneic cell therapies have a significant cost, convenience and efficiency advantage over autologous.
  • Data from three of the leaders: Allogene, Atara and CRISPR are expected in the next 12-to-24 months to further elucidate safety and efficacy.
  • The combination of high clinical failure rates and high net present values make oncology a priority investment segment.

For further details see:

Regenerative Medicines: Universal Cell Therapy Gaining Momentum
Stock Information
Company Name: Allogene Therapeutics Inc.
Stock Symbol: ALLO
Market: NASDAQ
Website: allogene.com
Menu
ALLO ALLO Quote ALLO Short ALLO News ALLO Articles ALLO Message Board
Get ALLO Alerts

News, Short Squeeze, Breakout and More Instantly...